Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Oligometastatic Prostate Carcinoma”

95 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 95 results

Not applicableNot Yet RecruitingNCT07237399
What this trial is testing

Percutaneous Thermo-ablation for the Treatment of Prostate Cancer Oligometastatasis (TA-P-OLIM)

Who this might be right for
Oligometastatic Prostate Cancer (OMPC)Prostate Cancer (Adenocarcinoma)Ablation Techniques
University Hospital, Ghent 50
Not applicableNot Yet RecruitingNCT06430411
What this trial is testing

Outcomes of Local Treatment for Oligometastatic Prostate Cancer Diagnosed Using PSMA PET Imaging: OLIGOMET Study

Who this might be right for
Prostate Cancer MetastaticProstate Cancer Metastatic to BoneProstate Cancer+3 more
Medical University of Vienna 500
Testing effectiveness (Phase 2)Looking for participantsNCT05915442
What this trial is testing

Adenosine Signaling Modulation and Immune Checkpoint Inhibition With Hormone Sensitive Oligometastatic Prostate Cancer

Who this might be right for
Oligometastatic Prostate Cancer
Catherine Spina 23
Large-scale testing (Phase 3)Looking for participantsNCT06972511
What this trial is testing

Maximal Tumor Eradication for Oligometastatic Prostate Cancer

Who this might be right for
Oligometastatic Prostate Cancer
RenJi Hospital 120
Not applicableLooking for participantsNCT06273345
What this trial is testing

OLIGOS: Impact of Treatment on Primary Tumour in Patients With Newly Diagnosed Oligometastatic Neoplasia of the Prostate

Who this might be right for
Oligometastatic Prostate Carcinoma
Istituto Oncologico Veneto IRCCS 150
Testing effectiveness (Phase 2)UnknownNCT04300673
What this trial is testing

Radio Guided Lymph Node Dissection in Oligometastatic Prostate Cancer Patients

Who this might be right for
Prostate CancerLymph Node Metastases
Radboud University Medical Center 20
Testing effectiveness (Phase 2)Active Not RecruitingNCT04748042
What this trial is testing

Focal Radiation With Pulsed Systemic Therapy of Abiraterone, Androgen Deprivation Therapy (ADT), Lynparza Towards Castration Sensitive Oligometastatic Prostate Cancer (FAALCON)

Who this might be right for
Prostate CancerCastrate Sensitive Prostate CancerOligometastatic Disease
University of Michigan Rogel Cancer Center 21
Testing effectiveness (Phase 2)Study completedNCT03007732
What this trial is testing

Pembrolizumab +/- SD-101 in Hormone-Naïve Oligometastatic Prostate Cancer With RT and iADT

Who this might be right for
Prostatic Neoplasms
David Oh 23
Not applicableWithdrawnNCT05245435
What this trial is testing

Diagnostic and Prognostic Accuracy of FDHT-PET and Liquid Biopsies in Prostate Cancer

Who this might be right for
Prostate Cancer
Medical University of Vienna
Not applicableStudy completedNCT02264379
What this trial is testing

Percutaneous High-dose Radiotherapy in Patients With Oligometastases of Prostate Carcinoma

Who this might be right for
Oligometastatic DiseaseProstate Cancer
Technische Universität Dresden 73
Testing effectiveness (Phase 2)Active Not RecruitingNCT04190446
What this trial is testing

Evaluate Hypofractionated Proton Therapy or IMRT for Recurrent, Oligometastatic Prostate Cancer

Who this might be right for
Metastatic Prostate AdenocarcinomaOligometastatic Prostate CarcinomaProstate Adenocarcinoma+2 more
Mayo Clinic 84
Large-scale testing (Phase 3)Active Not RecruitingNCT03525288
What this trial is testing

PSMA-PET Guided Radiotherapy

Who this might be right for
Prostate Cancer
Centre hospitalier de l'Université de Montréal (CHUM) 130
Testing effectiveness (Phase 2)Study completedNCT05146973
What this trial is testing

External Beam Therapy With Theranostic Radioligand Therapy for Oligometastatic Prostate Cancer (ProstACT TARGET)

Who this might be right for
Prostate Cancer
Telix Pharmaceuticals (Innovations) Pty Limited 5
Not applicableStudy completedNCT02170181
What this trial is testing

Clinical Registry for Oligometastic Disease, Consolidation Therapy, Debulking Prior to Chemotherapy, or Re-Irradiation

Who this might be right for
Cancer Patients Receiving Stereotactic Body RTX
University of Texas Southwestern Medical Center 149
Testing effectiveness (Phase 2)Active Not RecruitingNCT00544830
What this trial is testing

Hormone Therapy and Intensity-Modulated Radiation Therapy in Treating Patients With Metastatic Prostate Cancer

Who this might be right for
PSA Level Greater Than TwoStage IV Prostate Adenocarcinoma AJCC v7
City of Hope Medical Center 29
Testing effectiveness (Phase 2)Study completedNCT04992026
What this trial is testing

The Efficacy and Safety of Prostatectomy for Castration-Naive Oligometastatic Prostate Cancer

Who this might be right for
ProstatectomyOligometastatic Prostate CancerAbiraterone
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School 130
Testing effectiveness (Phase 2)UnknownNCT05212857
What this trial is testing

Enhanced Systemic Combined With Local Treatment for Primary and Metastatic Lesions in Oligo-metastatic Prostate Cancer

Who this might be right for
Prostate Cancer
Fudan University 160
Testing effectiveness (Phase 2)Looking for participantsNCT06150417
What this trial is testing

MDRT in Prostate Cancer Treated With Long-term Androgen Deprivation Therapy in the STAMPEDE Trial (METANOVA)

Who this might be right for
Prostate CancerMalignant Neoplasm of ProstateSecondary Malignant Neoplasm of Prostate
Case Comprehensive Cancer Center 200
Large-scale testing (Phase 3)Looking for participantsNCT06205316
What this trial is testing

SBRT Versus Hypofractionated Radiotherapy for Biochemically Recurrent or Oligometastatic Prostate Adenocarcinoma

Who this might be right for
Biochemically Recurrent Prostate CarcinomaOligometastatic Prostate CarcinomaRecurrent Prostate Adenocarcinoma+4 more
Mayo Clinic 118
Testing effectiveness (Phase 2)Active Not RecruitingNCT03569241
What this trial is testing

PEACE V: Salvage Treatment of OligoRecurrent Nodal Prostate Cancer Metastases

Who this might be right for
Prostate CancerProstate Cancer MetastaticMetastatic Cancer+1 more
University Hospital, Ghent 196
Load More Results